Highlights
NASDAQ: ESPR       Esperion Theraptc
Last Price Today's Change   Day's Range   Trading Volume
44.98   -3.33 (6.89%)  44.77 - 48.53  826,337

Overview

 
Avg Volume (4 weeks):875,573
4 Weeks Range:43.49 - 57.38
4 Weeks Price Volatility (%):
10.73%
52 Weeks Range:9.40 - 57.38
52 Weeks Price Volatility (%):
74.16%
Average Price Target: 93.00
Price Target Upside/Downside: +48.02

Headlines



No recent Headlines for this stock.


Business Background

Esperion Therapeutics, Inc. is a lipid management company. The Company is a late-stage pharmaceutical company focused on developing and commercializing once-daily, oral therapies for the treatment of patients with elevated low-density lipoprotein cholesterol (LDL-C). With a targeted mechanism of action, bempedoic acid, the Company's lead product candidate, is an orally available, once-daily adenosine triphosphate (ATP)-citrate lyase (ACL) inhibitor that reduces cholesterol biosynthesis and lowers elevated levels of LDL-C by up-regulating the LDL receptor, but with reduced potential for muscle-related side effects. In addition to bempedoic acid as monotherapy, the Company is also developing bempedoic acid in a fixed dose combination with ezetimibe, an approved, non-statin, oral, LDL-C lowering therapy. As of December 31, 2016, the Company was engaged in conducting its global Phase III clinical development program for bempedoic acid.

  Be the first to like this.
 


 

1659  5610  516  645 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 VXX 13.649+1.899 
 DCTH 0.168+0.027 
 SPY 243.14-3.80 
 UVXY 41.10+10.23 
 BAC 23.64-0.55 
 XLF 24.61-0.43 
 QQQ 141.33-2.95 
 EEM 43.29-0.57 
 BABA 163.92+4.42 
 CSCO 31.04-1.30 
Partners & Brokers